Ideas catalog
Every idea we've derived from recent research — the ones marked “Prototype” come with a live demo you can try.
A niche diagnostic tool with weak commercial pull, as it relies on low-to-moderate correlations from a single study to justify a complex multidisciplinary referral workflow.
A codifiable but narrowly differentiated configurator that translates a well-validated EU research architecture into SME guidance, held back by scattered beneficiaries, thin monetization logic, and modest novelty against existing assessment tools.
A generic AI-enhanced collaboration tool that lacks a specific technical edge and competes directly with established BI giants.
A well-framed deployment play for a genuinely promising therapy, but the entire business case hinges on FDA approval that has already been denied once (August 2024 CRL), and the evidence base is a single small trial with no independent corroboration.
A narrowly-scoped CBCT measurement tool built on a single small study of an unproven biomarker—technically feasible but commercially marginal as a standalone product.
A clinically grounded but narrow surgical-planning add-on built on a single 45-patient study, addressing a real complication in a tiny niche market with significant regulatory and validation hurdles.
A niche third-party fatigue-certification lab for self-ligating brackets built on a single in-vitro study showing minor degradation that the paper itself concludes is clinically inconsequential, leaving the commercial pain point thin.
A low-moat educational content play that attempts to monetize basic textbook physics without a clear software-driven value proposition.
A low-moat digitization of existing handbook data that offers little value to top-tier firms who already possess deep internal material libraries.
A mechanistically creative sperm-media additive concept anchored to a single paper on a rare genetic variant; real IVF-consumables market exists but the target population is tiny, the technical leap from in-vitro protein assay to stable media supplement is large, and existing antioxidant media already crowd the space.
Topical ESG-angle idea with real regulatory tailwinds, but fatally undermined by its own evidence base, which explicitly flags unresolved knowledge gaps in the very models the product would rely on.
A high-concept application of critical theory that lacks a concrete technical mechanism and faces severe misalignment with the primary goals of corporate HR.
A high-concept philosophical application of Judith Butler's ethics that lacks a concrete product mechanism and faces severe cultural resistance in corporate HR environments.
A theoretically grounded but evidence-thin pre-clinical mental health app with a genuinely novel framing that is undermined by a crowded market, an over-stacked intervention bundle, and a scattered GTM implied by naming employers, WHO, and FEMA as simultaneous buyers.
A high-concept GovTech tool that attempts to operationalize political theory into a software interface, but lacks a concrete functional mechanism and a clear commercial buyer.
A high-concept civic tech tool that attempts to operationalize political theory into a moderation API, but lacks a concrete technical mechanism for implementation.
A generic software utility for a mature market that lacks a specific competitive edge or a unique technical breakthrough beyond established textbook theory.
A focused retrofit concept with a genuine market need, but resting on a single small-dataset paper and entering a space already occupied by established AI video analytics vendors with no articulated technical moat.
A narrowly-scoped predictive heater control module addressing a real Euro 7 compliance pain point, but built on a single paper and squeezed between declining diesel and the very Tier-1 suppliers it hopes to license to.
A conceptually sound but vaguely defined assessment tool that lacks a concrete implementation mechanism beyond existing psychological theories.